Utah Medical Products
UTMD
77 hedge funds and large institutions have $155M invested in Utah Medical Products in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
3% more funds holding
Funds holding: 75 → 77 (+2)
1.59% more ownership
Funds ownership: 65.9% → 67.49% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 24
14% less capital invested
Capital invested by funds: $180M → $155M (-$25.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$10.1M |
| 2 |
Credit Agricole
Montrouge Cedex,
France
|
+$5.64M |
| 3 |
WCM Investment Management
Laguna Beach,
California
|
+$939K |
| 4 |
CYG
Clean Yield Group
Norwich,
Vermont
|
+$718K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$568K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
-$3.62M |
| 2 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
-$1.33M |
| 3 |
BPM
Bowling Portfolio Management
Cincinnati,
Ohio
|
-$661K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$390K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$328K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DA
76
Denali Advisors
San Diego,
California
| $2K | +$2.08K | +33 | New |
|
77
Barclays
London,
United Kingdom
| $1K | -$9.38K | -149 | -90% |
|
|
BPM
78
Bowling Portfolio Management
Cincinnati,
Ohio
| – | -$661K | -9,085 | Closed |
|
|
79
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$390K | -5,356 | Closed |
|
|
CCMH
80
Cornerstone Capital Management Holdings
New York
| – | -$21K | -300 | Closed |
|
|
PCM
81
Prelude Capital Management
New York
| – | -$22K | -300 | Closed |
|
UTMD Hedge Fund Activity: Q1 2017 in Review
77 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q1 2017, worth a combined $155M — down 14% from $180M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new UTMD positions and 4 closed out — a net gain of 6 holders — while 24 added to existing stakes and 24 trimmed.
The largest buyer was BlackRock, adding an estimated $10.1M. The largest seller was Nine Ten Capital Management, cutting an estimated $3.62M.
- 77 institutional investors held Utah Medical Products (UTMD) as of Q1 2017, up from 75 in Q4 2016.
- Funds reported $155M of Utah Medical Products stock for Q1 2017, down 14% quarter-over-quarter.
- 10 funds opened new Utah Medical Products positions in Q1 2017 and 4 closed out, a net change of +6 holders.
- The largest Utah Medical Products buyer in Q1 2017 was BlackRock, an estimated $10.1M added.
- The largest Utah Medical Products seller in Q1 2017 was Nine Ten Capital Management, an estimated $3.62M sold.
Based on aggregated 13F filings for Q1 2017.